News | Radiation Oncology | June 28, 2019

Varian to Provide Mobile Technology to Cancer Patients Across Tennessee

Collaboration with Tennessee Oncology aims to improve access to care across rural patient populations

 

Collaboration with Tennessee Oncology aims to improve access to care across rural patient populations

Providing cancer patients an opportunity for increased participation in their treatment, Varian announced its collaboration with Tennessee Oncology for the implementation of Noona, a software application for managing patient symptoms and capturing patient reported outcomes (PROs) in cancer care. As part of this collaboration, Noona will be deployed at more than 30 centers across Tennessee, with the goal of reaching approximately 25,000 patients per year.

The Tennessee Oncology network treats nearly 50 percent of all cancer patients in Tennessee, with a large percentage residing in rural settings. The implementation of Noona will provide these patients with a better way to communicate their symptoms and other relevant clinical information to their care team, while eliminating common barriers to adoption, such as patients' physical location or technology adeptness.

"We put patients first and seek out technology that goes the extra step. A desirable benefit of Noona's advanced information intelligence is the ability to more closely connect to our patient's quality of life and the advantage of aligning care to their changing needs," said Natalie Dickson, M.D., chief medical officer of Tennessee Oncology. "All patients deserve to receive the best quality of care regardless of where they live, and we are continually seeking ways to make that happen."

"Leveraging data and information technology hastens our goal of delivering the most advanced care to every newly diagnosed patient, wherever they live," adds Jeff Patton, M.D., chief executive officer of Tennessee Oncology. "Noona's outcome data collection pleasantly aligns with our value-based world. Our patients deserve our best."

"The healthcare industry strives to move from disease-centered to person-centered care—which requires us to capture information that describes the patient experience," said Corey Zankowski, Ph.D., senior vice president, Oncology Software Solutions, Varian. "Noona helps us achieve this goal by better connecting patients to their personal treatment and enabling clinicians to collect meaningful PRO data to adapt treatments for each patient and to predict future outcomes."

Noona is structured to collect a standardized dataset that is centered around patients' quality of life—including new or shifting symptoms that may signal a necessary shift in care. The interface is designed for an optimal user experience and with seamless access in mind. It may be accessed on any device with a web browser or through its native Apple or Android app. Patients are assigned a treatment module that aligns with their cancer type and allows them to regularly report and track their symptoms while sharing their questions and concerns instantly.

Positive outcomes reported from clinics worldwide that have already adopted Noona include:

  • Increased clinical efficiency and reduced workloads, saving up to 60 minutes per day, per user.
  • Improved information capture with a 90 percent patient response rate for symptom questionnaires.
  • More effective patient triage with algorithms that prioritize patients by symptom severity.   

Varian and Tennessee Oncology will work closely together through the end of 2019, and beyond, to focus on the continued adoption of the solution across its network.

For more information, visit www.varian.com/noona

Related Content

High-dose Radiation Effective for Men Whose Prostate Cancer Has Spread
News | Prostate Cancer | September 23, 2019
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the...
First Patients Treated With Machine Learning-generated Plans from RayStation 8B
News | Treatment Planning | September 23, 2019
The first-ever patient radiation therapy treatments generated with machine learning in the RayStation treatment...
An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

Feature | ASTRO | September 23, 2019
August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced th
Videos | Radiation Oncology | September 20, 2019
Anne Hubbard, MBA, director of health policy for ASTRO, explains the details and purpose of the proposed Radiation On
Videos | Radiation Therapy | September 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with...
Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019
News | Patient Positioning Radiation Therapy | September 20, 2019
Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual...
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
News | Proton Therapy | September 20, 2019
Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360...
Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), explains the details of the proposed radiation oncology alternative payment model (APM), and issues ASTRO has raised with the model, at the 2019 ASTRO annual meeting in Chicago.

News | Radiation Oncology | September 18, 2019
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the...
Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...